Ciurea A, Hunziker L, Klenerman P, Hengartner H, Zinkernagel R M
Institute for Experimental Immunology, University Hospital, CH-8091 Zürich, Switzerland.
J Exp Med. 2001 Feb 5;193(3):297-305. doi: 10.1084/jem.193.3.297.
We have shown previously that neutralizing antibodies (nAbs) are important contributors to the long-term immune control of lymphocytic choriomeningitis virus infection, particularly if cytotoxic T cell responses are low or absent. Nevertheless, virus escape from the nAb response due to mutations within the surface glycoprotein gene may subsequently allow the virus to persist. Here we show that most of the antibody-escape viral mutants retain their immunogenicity. We present evidence that the failure of the infected host to mount effective humoral responses against emerging neutralization-escape mutants correlates with the rapid loss of CD4(+) T cell responsiveness during the establishment of viral persistence. Similar mechanisms may contribute to the persistence of some human pathogens such as hepatitis B and C viruses, and human immunodeficiency virus.
我们之前已经表明,中和抗体(nAbs)是淋巴细胞性脉络丛脑膜炎病毒感染长期免疫控制的重要贡献者,特别是在细胞毒性T细胞反应较低或不存在的情况下。然而,由于表面糖蛋白基因内的突变,病毒从nAb反应中逃逸可能随后使病毒得以持续存在。在这里,我们表明大多数抗体逃逸病毒突变体保留了它们的免疫原性。我们提供的证据表明,受感染宿主未能对新出现的中和逃逸突变体产生有效的体液反应,这与病毒持续存在过程中CD4(+) T细胞反应性的迅速丧失有关。类似的机制可能有助于某些人类病原体如乙型和丙型肝炎病毒以及人类免疫缺陷病毒的持续存在。